GlassScriptPhysician profile
George A Cibulas
NPI 1144600198
$3,474.46
in general payments reported to CMS, 2019-2025
12 companies · $333 in 2025
The $333 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $19.22 · 2021: $1,554 · 2022: $67.53 · 2023: $184 · 2024: $1,147 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $981 · Travel and Lodging: $683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $981.28 |
| Travel and Lodging | $682.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Summit Surgical Corp. | $1,200.00 | 2021 | |
| Stryker Corporation | $832.00 | 2021-2025 | Gamma, Evolve, Axsos |
| Cgg Medical INC | $755.35 | 2024 | |
| Pinnacle, INC | $194.89 | 2024 | |
| Smith+Nephew, INC. | $170.07 | 2019 | |
| Arthrex, INC. | $108.00 | 2024 | |
| Trimed, INC. | $67.53 | 2022 | |
| Piedmont Plus Innovation | $51.87 | 2024 | |
| Axogen | $39.00 | 2021 | |
| Paratek Pharmaceuticals, INC. | $19.91 | 2024 | Nuzyra |
| Endo Pharmaceuticals INC. | $19.22 | 2020 | |
| Orthofix Medical, INC. | $16.62 | 2024 | Accelstim, Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Cibulas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.